Efficacy of Celsi Warmer for the Management of Hypothermic Newborns at the Lagos University Teaching Hospital in Lagos, Nigeria
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06003140 |
Recruitment Status :
Recruiting
First Posted : August 21, 2023
Last Update Posted : August 23, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Neonatal Hypothermia | Device: Celsi Warmer | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 90 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Efficacy of Low-cost Warming Mattress Celsi Warmer for the Management of Hypothermic Newborns at the Lagos University Teaching Hospital in Lagos, Nigeria |
Estimated Study Start Date : | August 15, 2023 |
Estimated Primary Completion Date : | October 21, 2024 |
Estimated Study Completion Date : | October 21, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Hypothermic Neonates (90)
A trained study clinician will attach the Celsi Warmer temperature sensor to the abdomen and secure it with the abdominal belt according to the device's instruction manual (such that the temperature sensor is positioned using a vertical line from the mid-clavicular line and just below the ribs). The time of sensor placement will be recorded.
|
Device: Celsi Warmer
A trained study clinician will attach the Celsi Warmer temperature sensor to the abdomen and secure it with the abdominal belt according to the device's instruction manual (such that the temperature sensor is positioned using a vertical line from the mid-clavicular line and just below the ribs). The time of sensor placement will be recorded. |
- Broad Objective - Comparison to the Gold Standard of Rewarming Hypothermic Newborns [ Time Frame: 1 year ]To evaluate the clinical efficacy and safety of the Celsi Warmer in rewarming hypothermic newborns by comparing the Celsi Warmer's accuracy in measuring neonatal temperature compared to the gold standard, axillary temperature readings.
- Efficacy of the Device [ Time Frame: 1 year ]To assess the performance of the Celsi Warmer in rewarming hypothermic newborns by measuring the incidence of attainment of normothermia (36.5-37.5°C)
- Safety of the Device - Rate of Temperature Increase [ Time Frame: 1 year ]To measure the infant's rate of temperature (°C) increase through thermoregulatory intervention.
- Safety of the Device - Local effect of the Abdominal Belt [ Time Frame: 1 year ]To evaluate the local effect of the abdominal belt on newborn's skin by looking at any evidence of skin irritation
- Safety of the Device - Incidence of Hyperthermia [ Time Frame: 1 year ]To evaluate any incidence of hyperthermia (>37.5°C) during the thermoregulation intervention.
- Safety of the Device - Incidence of Rebound Hypothermia [ Time Frame: 1 year ]To report any incidence of rebound hypothermia ( < 36.5°C) (post-intervention hypothermia) up to 72 hours from the initial encounter
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Day to 28 Days (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Any neonate who:
- Is currently being treated at study location,
- Is an inborn admission to the neonatal ward,
- Whose parents or guardians provided informed consent,
- Whose parents or guardians providing informed consent are 18 years old or older,
- Has a current weight of greater than or equal to 1.0 kg and less than or equal to 4.0 kg,
- Has been identified as in need of thermal care defined as having a moderate to severe hypothermic temperature (32.0-36.0 °C) as the last temperature recorded in hospital chart, or during recruitment procedures; and
- is unable to be enrolled in Kangaroo Mother Care (KMC) for reasons including, but not limited to: a. Mother/guardian unable or unavailable to provide KMC b. Under observation in the Neonatal Intensive Care Unit (NICU) before transfer to KMC c. No space in KMC d. Clinician's discretion;
- May be receiving other medical treatments, including but not limited to, Continuous Positive Airway Pressure (CPAP), oxygen therapy, intravenous (IV) fluids, management and monitoring of common newborn conditions such as hypoglycemia, and/or hyperbilirubinemia.
Exclusion Criteria:
- Requires mechanical ventilation;
- Is deemed in need of intensive care by the hospital staff who is providing care, including but not limited to: a. neonates with severe anemia and/or any suspected hematological disorders, and/or b. Neonates with obvious congenital anomalies, and/or c. neonates suspected with hypo/hyperthyroidism or any hormonal disorders;
- has been diagnosed with birth asphyxia;
- Presents a condition that precludes the use of the temperature sensor and/or abdominal belt including but not limited to, known umbilical cord infection, known skin infection;
- Whose clinician presents concerns about their participation;
- Is receiving treatment that participation in the study would interfere with (e.g. transferring to KMC).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06003140
Contact: Rebecca Massey, MPH, BSN, RN | 7133482923 | rebecca.elias@rice.edu | |
Contact: Sonia Sosa Saenz, BME | soniasosa@rice.edu |
Nigeria | |
University of Lagos, Lagos, Nigeria | Recruiting |
Lagos, Nigeria | |
Contact: Chinyere Ezeaka, MBBS |
Principal Investigator: | Chinyere Ezeaka, MBBS, MPH | College of Medicine, University of Lagos, Lagos, Nigeria |
Responsible Party: | William Marsh Rice University |
ClinicalTrials.gov Identifier: | NCT06003140 |
Other Study ID Numbers: |
2023-69 |
First Posted: | August 21, 2023 Key Record Dates |
Last Update Posted: | August 23, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Hypothermia Body Temperature Changes |